PAREXEL Recognized as a 2017 “Training Top 125” by Training Magazine
January 31 2017 - 10:00AM
Business Wire
Company acknowledged for excellence in
employer-sponsored training and development programs
PAREXEL International Corporation (NASDAQ: PRXL), a leading
global biopharmaceutical services provider, today announced that
the Company has been recognized among top U.S. businesses in
Training magazine’s annual “Training Top 125.” This year marks the
second time PAREXEL earned a place in the Training Top 125 for
developing creative and effective learning and development
initiatives for its global workforce.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170131005740/en/
PAREXEL's Albert Siu and Anke Nissen
accept a 2017 Training magazine Training Top 125 award on behalf of
the company. PAREXEL ranked 38 among the top 125 companies. (Photo:
Business Wire)
“At PAREXEL, our employees are our core asset and give us our
competitive edge. Developing their capabilities is a key component
of our people strategy. From traditional instructor-led delivery to
eLearning environments, PAREXEL provides best-in-class learning
products and customized training programs,” said Albert Siu, Vice
President, Learning and Development, PAREXEL. “Our focus is to
deliver the right training, to the right people, at the right time
to ensure our employees are prepared to succeed in their jobs and
careers. Having expertly trained employees around the globe is
essential in helping our clients bring new drugs to patients.”
PAREXEL’s comprehensive learning and training programs encompass
four primary learning domains including: company culture and
strategy; functional competencies; leadership development; and
professional development. The Company’s Learning and Development
organization is recognized for its effective and efficient training
infrastructure. All delivered programs have a unique set of
performance metrics to measure effectiveness across learning
disciplines.
“PAREXEL impressed us with its training focus that aligns to the
requirements and needs of the business, while offering employees
valuable career and job skills development,” said Lorri Freifeld,
editor-in-chief, Training magazine. “The competition was fierce
this year, and PAREXEL’s global learning and development
initiatives earned the Company this well-deserved spot in our 2017
ranking.”
In addition to training employees, PAREXEL is committed to
developing the future, global biopharmaceutical workforce with
courses specifically tailored to meet the growing talent needs of
the clinical development market. Since 2001, the PAREXEL Academy
has designed and implemented a wide range of learning and
performance programs to teach clinical research management for
learners outside of PAREXEL. The PAREXEL Academy has locations in
Asia, Europe, and the United States. Since inception, more than
1,000 students have graduated from the Academy’s programs.
For more than 15 years, Training magazine, the leading business
publication for learning and development professionals, has issued
its annual “Training Top 125,” which ranks companies’ excellence in
employer-sponsored training and development programs. The rankings
are based on myriad benchmarking statistics such as total training
budget as a percentage of payroll; number of training hours
invested per employee; training results based on evaluation and
measurement of outcomes and business impact; and workplace survey
results. In addition, a detailed and formal peer review evaluation
process is conducted to determine the final ranking outcomes.
About PAREXEL InternationalPAREXEL International
Corporation is a leading global biopharmaceutical services company,
providing a broad range of expertise-based clinical research,
consulting, medical communications, and technology solutions and
services to the worldwide pharmaceutical, biotechnology and medical
device industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, and
reimbursement. PAREXEL Informatics provides advanced technology
solutions, including medical imaging, to facilitate the clinical
development process. Headquartered near Boston, Massachusetts,
PAREXEL has offices in 85 locations in 51 countries around the
world, and had approximately 18,750 employees in the first quarter.
For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Academy are trademarks or registered
trademarks of PAREXEL International Corporation or its affiliates.
All other trademarks are the property of their respective
owners.
This release contains “forward-looking” statements regarding
future results and events. For this purpose, any statements
contained herein that are not statements of historical fact may be
deemed forward-looking statements. Without limiting the foregoing,
the words “believes,” “anticipates,” “plans,” “expects,” “intends,”
“appears,” “estimates,” “projects,” “will,” “would,” “could,”
“should,” “targets,” and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements
in this release involve a number of risks and uncertainties. Such
factors and others are discussed in the section entitled “Risk
Factors” of the Company’s most recent Annual Report on Form 10-K
and subsequent quarterly reports on Form 10-Q filed with the
Securities and Exchange Commission, which “Risk Factors” discussion
is incorporated by reference in this press release. The Company
specifically disclaims any obligation to update these
forward-looking statements in the future. These forward-looking
statements should not be relied upon as representing the Company’s
estimates or views as of any date subsequent to the date of this
press release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170131005740/en/
Media:Cristi BarnettTel.: +1 781-434-4019Email:
Cristi.Barnett@PAREXEL.comorJenny Radloff, PAN CommunicationsTel:
+1 617-502-4300Email: PAREXEL@pancomm.comorInvestors:Ronald
AldridgeTel.: +1-781-434-4753Email: ron.aldridge@PAREXEL.com
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Apr 2024 to May 2024
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From May 2023 to May 2024